Schizophrenia
The Schizophrenia pipeline: 62 tracked drugs, 30 approved for this indication.
30 approved / phase 410 Phase 312 Phase 22 Phase 1/27 Phase 11 preclinical / unstaged
Compare the share prices of listed companies in Schizophrenia →
Total attributable cost
$49.0B
$15,957/patient
Drug spend
Not yet sourced
All severities · US
The Schizophrenia pipeline
Key trial results for every approved and late-stage drug: Schizophrenia results by drug.